206,152 Canadians
will be diagnosed with cancer
this year
Nearly 1 in 2 Canadians is expected to be diagnosed with cancer in their lifetime.
The findings are part of a report published in June of 2017 - Canadian Cancer Statistic 2017 - released by the Canadian Cancer Society in partnership with the Public Health Agency of Canada and Statistics Canada.
Canadians 50 years of age and older
will make up almost 42% of
new cancer cases.
The report emphasizes that the rise in cancer cases is primarily being driven by an aging and growing population. As more people live into old age, the number of cancer cases will continue to rise.
80,752 Canadians
will die of cancer this year
This makes cancer the leading cause of death in Canada. Great progress has been made so far in the fight against cancer, but there is more that must be done.
As one of the top 5 cancer research centres in the world, we are committed to transforming cancer care through discovery research and clinical innovations that set new standards of care for Canada and the world.
The Princess Margaret
One of the top
0.
cancer research centres in the world
Ranked
0th
for percentage of papers published in high-impact journals
Ranked
0th
for percentage of highly cited papers
At The Princess Margaret, personalized cancer medicine is at the heart of our vision: Conquer Cancer In Our Lifetime. This is an overarching whole-person approach to patient care. It’s about the right treatment for the right patient, at the right time. Detecting cancers early leads to better outcomes. We have been discovering new biomarkers and developing new molecular imaging technology that can visualize even the smallest cancers.
Analyzing cancers in greater depth will lead to a better understanding of each patient's disease and a more customized and effective treatment. Our cancer genomics program, for example, is helping to identify the DNA mutations and molecular mechanisms that drive cancer. At the same time, we've been working to target surgery, radiation and drug treatments more precisely so we can eliminate cancers while leaving more healthy tissue intact. Guided therapeutics and genomics are being implemented and are showing promise. New treatments, like immunotherapy, are advancing rapidly and have the potential to significantly impact survival rates.
While we are focused on the treatment of the disease, we also support cancer care for the whole patient. We are dedicated to assisting those who are affected by cancer by providing services that focus on physical, emotional, psychological and social needs throughout the cancer journey. Our researchers are world renowned for their leadership in supportive care and continue to strive for new ways of assisting patients.
^ Return to top
Over 807 researchers and research staff employed including
0
Senior Scientists
0
Affiliate Scientists
0
Scientists
234
Cancer Clinical Research Unit (CCRU) members
The quality of the research being done at The Princess Margaret is second to none in Canada.
The Princess Margaret has a track record of world firsts and discoveries which include: stem cells, cloning the T-cell receptor, colon cancer stem cells, lung cancer signature, a new view on how blood is made, root cause of myeloma relapse, liquid biopsy biomarkers to identify aggressive prostate cancer and many more.
Princess Margaret Cancer Centre offers real hope in areas such as:
New, more effective therapies
1 in 6 patients are on an active clinical trial looking for tomorrow’s treatment today and sharing the knowledge with other cancer centres in Canada and around the world.
The Princess Margaret leads the Phase II Consortium collaborating with 10 other cancer centres across Canada on new drug trials